CARB-X supports BioVersys' development of pyrrolocytosines targeting antibiotic-resistant bacteria June 1, 2021
Preclinical data show antiviral and anti-inflammatory activity of balixafortide in COVID-19 June 1, 2021
CARB-X grant supports development of SNIPR-001 to prevent E. coli infections in cancer patients May 31, 2021
RSS